Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_07c9542186133097bd6bbb7d92393090 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-007 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-203 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-203 |
filingDate |
2016-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a1d6e947ab7a9773411d70d524d967f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca71909df1fb5560aba5cc216ed2b6c7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aadfe0e29180772b92eabf6281acd83e |
publicationDate |
2017-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2017100358-A1 |
titleOfInvention |
Use of retinoic acid and analogs thereof to treat central neural apneas |
abstract |
Described is a method of inhibiting central apnea, central hypopnea or obstructive sleep apnea in a mammal. The method includes the step of administering to a mammal a central apnea inhibitory-effective, central hypopnea inhibitory-effective or obstructive sleep apnea inhibitory-effective amount of a composition comprising at least one retinoid or retinoid or retinoic acid receptor agonist. |
priorityDate |
2015-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |